Table 1 Characteristics of the Study Cohort
Entire Study Cohort | ||
|---|---|---|
Characteristic | MS (N = 704) | Control (N = 5381) |
Gender | ||
Female | N = 460 (65.3%) | N = 3857 (71.7%) |
Male | N = 243 (34.5%) | N = 1524 (28.3%) |
Nonbinary | N = 1 (0.1%) | N = 0 (0%) |
Age | ||
Pediatric (≤18 years) | N = 265 (37.6%) | N = 654 (12.2%) |
Adult (>18 years) | N = 439 (62.4%) | N = 4727 (87.8%) |
Median Age (range) | 34.5 (7.2 – 59.7) | 39.4 (7.7 − 70) |
Retrospective Longitudinal Cohort | ||
Characteristic | MS (N = 324) | Control (N = 324) |
Gender | ||
Female | N = 220 (67.9%) | N = 220 (67.9%) |
Male | N = 104 (32.1%) | N = 104 (32.1%) |
Age | ||
Pediatric (≤18 years) | N = 21 (6.5%) | N = 21 (6.5%) |
Adult (>18 years) | N = 303 (93.5%) | N = 303 (93.5%) |
Median Age (min-max) | 39.5 (7.2 – 53.1) | 40.4 (7.7 – 52.4) |
Primary EBV-Infection | ||
Infectious Mononucleosis | N = 264 (81.5%) | N = 264 (81.5%) |
Asymptomatic | N = 60 (18.5%) | N = 60 (18.5%) |
